凝析物作为RAS激活和抑制剂抵抗的罪祸首
Hannah C Bergo1,2,3, Logan B Leak1,2,3, Trever G Bivona1,2,3,4
1Department of Medicine, University of California, San Francisco, San Francisco, California.
Cancer research
|March 7, 2025
概括
ARAF蛋白形成新的凝聚物,维持RAS信号传输,在癌症中驱动治疗抵抗力. 针对这些ARAF-RAS凝聚物可能可以克服对RAS向治疗的耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 治疗耐药性是癌基因驱动癌症死亡的主要原因.
- 了解抵抗机制对于开发有效的癌症治疗至关重要.
研究的目的:
- 在向癌症治疗中阐明一种新的抵抗机制.
- 研究ARAF在RAS介导信号传递和治疗耐药性中的作用.
主要方法:
- 研究了ARAF在RAS信号传输中的功能.
- 利用技术研究蛋白质相互作用和局部化.
- 研究了ARAF在相隔冷凝液中的作用.
主要成果:
- ARAF在等离子膜的相分离冷凝物中隔离了活性RAS.
- 这种隔离维持了MAPK通路的信号传递,并防止了神经纤维素1对RAS的失活.
- 与其他RAF蛋白相比,ARAF具有独特的生物作用.
结论:
- 在通过生物分子凝聚物维持RAS信号传递方面,ARAF发挥着新的作用.
- 这种机制有助于RAS驱动的癌症的治疗耐药性.
- 准ARAF介导的冷凝剂是克服治疗耐药性的潜在策略.
更多相关视频
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.2K
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
918
相关概念视频
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K
